We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+24.95%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.44B
AUM Growth
-$42.2M
Cap. Flow
-$133M
Cap. Flow %
-9.26%
Top 10 Hldgs %
29.23%
Holding
202
New
26
Increased
19
Reduced
11
Closed
39

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$34.8M
2
X
US Steel
X
+$34.6M
3
AGR
Avangrid, Inc.
AGR
+$32.7M
4
WS icon
Worthington Steel
WS
+$26.7M
5
CTLT
CATALENT, INC.
CTLT
+$25M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$64.7M
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$62.7M
3
WFRD icon
Weatherford International
WFRD
+$56.8M
4
DELL icon
Dell
DELL
+$37.5M
5
SPLK
Splunk Inc
SPLK
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 12.86%
2 Consumer Discretionary 12.47%
3 Financials 11.09%
4 Industrials 7.54%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DFP
51
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$425M
$8.81M 0.61%
459,627
– –
SLN
52
Silence Therapeutics
SLN
$529M
$8.32M 0.58%
+385,408
New +$8.38M
DUETW
53
DELISTED
DUET Acquisition Corp. Warrant
DUETW
$8.23M 0.57%
750,000
– –
GRMLW
54
Greenland Mines Ltd Warrant
GRMLW
$8.21M 0.57%
686,003
-130,400
-16% -$6.47K
CHW
55
Calamos Global Dynamic Income Fund
CHW
$520M
$8.02M 0.56%
1,231,838
+54,781
+5% +$334K
PDT
56
John Hancock Premium Dividend Fund
PDT
$634M
$7.93M 0.55%
681,031
+65,372
+11% +$731K
CNH
57
CNH Industrial
CNH
$13.5B
$7.88M 0.55%
+607,678
New +$7.35M
VYX icon
58
NCR Voyix
VYX
$1.19B
$7.56M 0.53%
598,730
– –
PUCKW
59
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$7.33M 0.51%
678,800
– –
CLRCW
60
DELISTED
ClimateRock Warrant
CLRCW
$7.3M 0.51%
650,000
– –
ASCBW
61
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
$7.17M 0.5%
643,525
– –
EMCGW
62
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
$6.96M 0.48%
625,000
– –
GLO
63
Clough Global Opportunities Fund
GLO
$243M
$6.76M 0.47%
1,330,091
+102,647
+8% +$501K
LRMR icon
64
Larimar Therapeutics
LRMR
$387M
$6.5M 0.45%
855,815
+50,000
+6% +$390K
IGTAW
65
DELISTED
Inception Growth Acquisition Limited Warrants
IGTAW
$6.28M 0.44%
578,150
– –
RIV
66
RiverNorth Opportunities Fund
RIV
$307M
$6.21M 0.43%
515,627
+10,376
+2% +$121K
ALSAW
67
DELISTED
Alpha Star Acquisition Corp Warrants
ALSAW
$5.67M 0.39%
500,000
– –
DISTW
68
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$5.65M 0.39%
525,090
– –
TETEW
69
DELISTED
Technology & Telecommunication Acquisition Corporation Warrant
TETEW
$5.64M 0.39%
482,590
– –
IXAQW
70
DELISTED
IX Acquisition Corp. Warrant
IXAQW
$5.6M 0.39%
500,000
– –
DJT icon
71
PUT
Trump Media & Technology Group
DJT
$2.69B
$5.58M 0.39%
+90,000
New +$3.49M
AIMAW
72
DELISTED
Aimfinity Investment Corp I Warrant
AIMAW
$5.55M 0.39%
500,026
– –
CCTSW
73
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
$5.55M 0.39%
499,600
– –
MAQCW
74
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$5.46M 0.38%
499,002
– –
QOMOW
75
DELISTED
Qomolangma Acquisition Corp. Warrant
QOMOW
$5.45M 0.38%
500,000
– –
1 2
3
4 5

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Mangrove Partners held 202 positions worth $1.44B, down 2.8% from $1.48B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Mangrove Partners withdrew a net $133M in Q1 2024, closing 39 positions and reducing 11 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $64.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.6% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Mangrove Partners opened a new position in Teva Pharmaceuticals worth $39M.

  • Mangrove Partners's largest Q1 2024 buy was Teva Pharmaceuticals: 2,762,154 shares worth $39M.
  • Mangrove Partners added most to US Steel in Q1 2024, an estimated $34.6M increase.
  • Mangrove Partners's biggest Q1 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $62.7M.
  • Mangrove Partners fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $64.7M.
  • Mangrove Partners's ten largest holdings make up 29% of its $1.44B portfolio in Q1 2024.
  • Mangrove Partners opened 26 new positions and closed 39 in Q1 2024.
  • Mangrove Partners's portfolio value fell 2.8% quarter-over-quarter to $1.44B.

Based on Mangrove Partners's 13F filing for Q1 2024, filed 15 May 2024.